首页 > 最新文献

Current Urology Reports最新文献

英文 中文
Contemporary Use of Computed Tomography (CT) Imaging in Suspected Urolithiasis in Pregnancy. 当代计算机断层扫描(CT)在妊娠期疑似尿石症中的应用。
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-09-01 DOI: 10.1007/s11934-023-01171-8
Nicholas S Dean, Amy E Krambeck

Purpose of review: We aimed to examine the role of low-dose CT (LDCT) in the diagnostic work-up for suspected urolithiasis in pregnancy. We reviewed contemporary urologic recommendations for CT in pregnancy, its utilization for suspected urolithiasis, and explored barriers to its use.

Recent findings: National urologic guidelines and the American College of Obstetricians and Gynecologists recommend the judicious use of LDCT imaging in pregnancy when necessary. We noted inconsistencies in review article management pathways and recommendations for CT imaging for suspected urolithiasis in pregnancy. Overall CT utilization in pregnancy for suspected urolithiasis is low. Proposed barriers to LDCT use in pregnancy include fears of litigation and misperceptions of the harm of diagnostic radiation. Recent advancements in imaging technologies for urolithiasis in pregnancy are limited. More specific diagnostic pathway recommendations from national urologic guideline bodies for when to use LDCT to investigate renal colic in pregnancy may reduce diagnostic and intervention delays.

回顾目的:我们旨在探讨低剂量CT (LDCT)在妊娠期疑似尿石症诊断中的作用。我们回顾了当代泌尿科对妊娠期CT的建议,其在疑似尿石症中的应用,并探讨了其使用的障碍。最新发现:国家泌尿外科指南和美国妇产科医师学会建议在必要时明智地在怀孕期间使用LDCT成像。我们注意到在回顾性文献中,对妊娠期疑似尿石症的CT成像的管理途径和建议存在不一致。妊娠期疑似尿石症的CT总体使用率较低。在怀孕期间使用LDCT的障碍包括对诉讼的恐惧和对诊断辐射危害的误解。妊娠期尿石症成像技术的最新进展有限。国家泌尿系统指南机构关于何时使用LDCT检查妊娠期肾绞痛的更具体的诊断途径建议可能会减少诊断和干预的延迟。
{"title":"Contemporary Use of Computed Tomography (CT) Imaging in Suspected Urolithiasis in Pregnancy.","authors":"Nicholas S Dean,&nbsp;Amy E Krambeck","doi":"10.1007/s11934-023-01171-8","DOIUrl":"https://doi.org/10.1007/s11934-023-01171-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>We aimed to examine the role of low-dose CT (LDCT) in the diagnostic work-up for suspected urolithiasis in pregnancy. We reviewed contemporary urologic recommendations for CT in pregnancy, its utilization for suspected urolithiasis, and explored barriers to its use.</p><p><strong>Recent findings: </strong>National urologic guidelines and the American College of Obstetricians and Gynecologists recommend the judicious use of LDCT imaging in pregnancy when necessary. We noted inconsistencies in review article management pathways and recommendations for CT imaging for suspected urolithiasis in pregnancy. Overall CT utilization in pregnancy for suspected urolithiasis is low. Proposed barriers to LDCT use in pregnancy include fears of litigation and misperceptions of the harm of diagnostic radiation. Recent advancements in imaging technologies for urolithiasis in pregnancy are limited. More specific diagnostic pathway recommendations from national urologic guideline bodies for when to use LDCT to investigate renal colic in pregnancy may reduce diagnostic and intervention delays.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 9","pages":"443-449"},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10079721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement. 前列腺动脉栓塞治疗良性前列腺肿大相关下尿路症状。
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-09-01 DOI: 10.1007/s11934-023-01170-9
Patrick Curtin, Christopher Chang, Andre Uflacker

Purpose of review: Prostatic artery embolization (PAE) is an emerging minimally invasive technique for lower urinary tract symptom reduction from benign prostatic hypertrophy (BPH). While the technique is becoming increasingly popular with patients and interventional radiologists, most urologists remain skeptical of the PAE's long-term efficacy and comparative success to the gold standard transurethral resection of the prostate.

Recent findings: PAE has been found in multiple meta-analyses to perform similarly to the gold standard transurethral resection of the prostate (TURP) with regard to patient-driven measures like IPSS and IPSS-QoL, while also performing favorably in objective measurements including Qmax and PVR out to at least 12 months post intervention. Furthermore, PAE has a demonstrated shorter hospital length of stay and fewer adverse events when compared to TURP. PAE provides patients with an alternative to transurethral options for the management of LUTS in the setting of bladder outlet obstruction. While long-term evidence demonstrating the durability of PAE is still forthcoming, the procedure has been demonstrated to be safe according to multiple meta-analyses. Patients deserve to be counseled on PAE as an alternative to surgery and made aware that while the overall treatment effect may not be as robust or durable, the procedure carries a favorable adverse event profile that is attractive to patients wishing to avoid a trans-urethral approach.

回顾目的:前列腺动脉栓塞(PAE)是一种新兴的微创技术,用于减少良性前列腺肥大(BPH)的下尿路症状。虽然这项技术越来越受到患者和介入放射科医生的欢迎,但大多数泌尿科医生仍然对PAE的长期疗效和与金标准经尿道前列腺切除术相比的成功持怀疑态度。最近的发现:在多个荟萃分析中发现,PAE在患者驱动的测量指标(如IPSS和IPSS- qol)方面的表现与金标准经尿道前列腺切除术(TURP)相似,同时在干预后至少12个月的客观测量指标(包括Qmax和PVR)中也表现良好。此外,与TURP相比,PAE具有较短的住院时间和较少的不良事件。在膀胱出口梗阻的情况下,PAE为LUTS的治疗提供了经尿道选择的另一种选择。虽然还没有长期证据证明PAE的持久性,但根据多项荟萃分析,该手术已被证明是安全的。患者应该被告知PAE作为手术的替代方案,并意识到尽管整体治疗效果可能不那么稳健或持久,但该手术具有良好的不良事件特征,对希望避免经尿道入路的患者具有吸引力。
{"title":"Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement.","authors":"Patrick Curtin,&nbsp;Christopher Chang,&nbsp;Andre Uflacker","doi":"10.1007/s11934-023-01170-9","DOIUrl":"https://doi.org/10.1007/s11934-023-01170-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Prostatic artery embolization (PAE) is an emerging minimally invasive technique for lower urinary tract symptom reduction from benign prostatic hypertrophy (BPH). While the technique is becoming increasingly popular with patients and interventional radiologists, most urologists remain skeptical of the PAE's long-term efficacy and comparative success to the gold standard transurethral resection of the prostate.</p><p><strong>Recent findings: </strong>PAE has been found in multiple meta-analyses to perform similarly to the gold standard transurethral resection of the prostate (TURP) with regard to patient-driven measures like IPSS and IPSS-QoL, while also performing favorably in objective measurements including Qmax and PVR out to at least 12 months post intervention. Furthermore, PAE has a demonstrated shorter hospital length of stay and fewer adverse events when compared to TURP. PAE provides patients with an alternative to transurethral options for the management of LUTS in the setting of bladder outlet obstruction. While long-term evidence demonstrating the durability of PAE is still forthcoming, the procedure has been demonstrated to be safe according to multiple meta-analyses. Patients deserve to be counseled on PAE as an alternative to surgery and made aware that while the overall treatment effect may not be as robust or durable, the procedure carries a favorable adverse event profile that is attractive to patients wishing to avoid a trans-urethral approach.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 9","pages":"427-441"},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10133279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Outcomes of Paediatric Cystine Stone Management: Results of a Systematic Review. 儿科胱氨酸结石治疗的结果:一项系统评价的结果。
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01162-9
Francesco Ripa, Amelia Pietropaolo, Robert Geraghty, Stephen Griffin, Paul Cook, Bhaskar Somani

Purpose of review: We wanted to analyse the outcomes of surgical (SWL, URS, PCNL) and medical management of cystine stones in the paediatric population in terms of stone-free status and complication rates, based on all the available literature evidence.

Recent findings: A systematic review of literature was performed for all studies with paediatric cystine stone management. Twelve studies met the eligibility criteria, of which 4 analysed outcomes of SWL, 2 of URS and 3 of PCNL and 3 focused on the effect of either alkalising agents (potassium citrate, citric acid) or cysteine-binding thiol (CBT) agents (tiopronin, penicillamine). The reported SFR in studies ranged from 50 to 83%, 59 to 100% and 63 to 80.6%, with a complication rate of 2.8-51%, 14-27% and 12.9-15.4% with SWL, URS and PCNL, respectively. Paediatric cystine stones treatment should aim at complete stone clearance, preservation of renal function and prevention of further recurrences. SWL achieves inferior results in case of cystine stones. URS and PCNL are safe and effective procedures in the paediatric population, with a low rate of major complications. Adherence to medical prevention therapies may prolong recurrence-free periods.

回顾的目的:我们希望根据所有可用的文献证据,分析儿科人群中胱氨酸结石的手术(SWL、URS、PCNL)和医疗管理的结果,包括无结石状态和并发症发生率。最近的发现:对所有关于小儿胱氨酸结石管理的研究进行了系统的文献回顾。12项研究符合入选标准,其中4项研究分析了SWL的结果,2项研究分析了URS的结果,3项研究分析了PCNL的结果,3项研究关注了碱化剂(柠檬酸钾、柠檬酸)或半胱氨酸结合硫醇(CBT)剂(硫丙肽、青霉胺)的效果。研究报告的SFR为50 ~ 83%、59 ~ 100%和63 ~ 80.6%,SWL、URS和PCNL的并发症发生率分别为2.8 ~ 51%、14 ~ 27%和12.9 ~ 15.4%。小儿胱氨酸结石的治疗应以完全清除结石、保存肾功能和预防进一步复发为目标。在胱氨酸结石的情况下,SWL的效果较差。URS和PCNL在儿科人群中是安全有效的手术,主要并发症发生率低。坚持医学预防疗法可延长无复发期。
{"title":"Outcomes of Paediatric Cystine Stone Management: Results of a Systematic Review.","authors":"Francesco Ripa,&nbsp;Amelia Pietropaolo,&nbsp;Robert Geraghty,&nbsp;Stephen Griffin,&nbsp;Paul Cook,&nbsp;Bhaskar Somani","doi":"10.1007/s11934-023-01162-9","DOIUrl":"https://doi.org/10.1007/s11934-023-01162-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>We wanted to analyse the outcomes of surgical (SWL, URS, PCNL) and medical management of cystine stones in the paediatric population in terms of stone-free status and complication rates, based on all the available literature evidence.</p><p><strong>Recent findings: </strong>A systematic review of literature was performed for all studies with paediatric cystine stone management. Twelve studies met the eligibility criteria, of which 4 analysed outcomes of SWL, 2 of URS and 3 of PCNL and 3 focused on the effect of either alkalising agents (potassium citrate, citric acid) or cysteine-binding thiol (CBT) agents (tiopronin, penicillamine). The reported SFR in studies ranged from 50 to 83%, 59 to 100% and 63 to 80.6%, with a complication rate of 2.8-51%, 14-27% and 12.9-15.4% with SWL, URS and PCNL, respectively. Paediatric cystine stones treatment should aim at complete stone clearance, preservation of renal function and prevention of further recurrences. SWL achieves inferior results in case of cystine stones. URS and PCNL are safe and effective procedures in the paediatric population, with a low rate of major complications. Adherence to medical prevention therapies may prolong recurrence-free periods.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"371-380"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9943567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease-A Systematic Review of the Literature. 修正:尿pH值监测在肾结石疾病中的作用、成本和有效性——对文献的系统回顾。
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01176-3
Isabel Sanz-Gómez, Oriol Angerri, Michael Baboudjian, Andrés Kanashiro, Sílvia Gracia, Félix Millán, Francisco Sánchez-Martín, Bhaskar Somani, Juan Antonio Galan-Llopis, Yazeed Barghouthy, Esteban Emiliani
{"title":"Correction: Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease-A Systematic Review of the Literature.","authors":"Isabel Sanz-Gómez,&nbsp;Oriol Angerri,&nbsp;Michael Baboudjian,&nbsp;Andrés Kanashiro,&nbsp;Sílvia Gracia,&nbsp;Félix Millán,&nbsp;Francisco Sánchez-Martín,&nbsp;Bhaskar Somani,&nbsp;Juan Antonio Galan-Llopis,&nbsp;Yazeed Barghouthy,&nbsp;Esteban Emiliani","doi":"10.1007/s11934-023-01176-3","DOIUrl":"https://doi.org/10.1007/s11934-023-01176-3","url":null,"abstract":"","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"389"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10288387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selection and Outcomes for Dissolution Therapy in Uric Acid Stones: A Systematic Review of Literature. 尿酸结石溶出治疗的选择和结果:文献系统综述。
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01164-7
Andrea Ong, George Brown, Theodoros Tokas, B M Zeeshan Hameed, Joe Philip, Bhaskar K Somani

Purpose of review: The prevalence of uric acid (UA) urolithiasis contributes significantly to global disease burden, due to high rates of recurrence and diagnostic challenges. Dissolution therapy plays a valuable role in the conservative management of UA calculi, reducing the requirement for surgical intervention. This review summarises the existing evidence for the efficacy of medical dissolution of uric acid urolithiasis.

Recent findings: A systematic search was conducted of worldwide literature according to PRISMA methodology and Cochrane standards for systematic review. Studies were included if they reported outcome data for the administration of medical therapy for the dissolution of UA calculi. A total of 1075 patients were included in the systematic review. Complete or partial dissolution of UA calculi was observed in 80.5% of patients (865/1075 patients), with 61.7% (647/1048 patients) achieving complete dissolution and 19.8% (207/1048 patients) achieving partial dissolution. A discontinuation rate of 10.2% (110/1075 patients) was noted, and 15.7% (169/1075 patients) required surgical intervention. Dissolution therapy is a safe and effective method of conservatively managing uric acid stones in the short term. Despite the significant disease burden of UA calculi, current guidelines are limited by deficiencies in the existing body of research. Further research should be undertaken to develop evidence-based clinical guidelines for diagnosis, treatment, and prevention of UA urolithiasis.

综述目的:尿酸(UA)尿石症的患病率显著增加了全球疾病负担,因为其复发率高且诊断困难。溶出治疗在UA结石的保守治疗中发挥了重要作用,减少了手术干预的需要。本文综述了药物溶尿酸尿石症疗效的现有证据。最近发现:根据PRISMA方法和Cochrane系统评价标准,对全球文献进行了系统检索。如果研究报告了UA结石溶解药物治疗的结果数据,则纳入研究。系统评价共纳入1075例患者。80.5%的患者(865/1075例)发现UA结石完全或部分溶解,61.7%(647/1048例)达到完全溶解,19.8%(207/1048例)达到部分溶解。停药率为10.2%(110/1075例),15.7%(169/1075例)需要手术干预。溶栓治疗是一种安全有效的短期保守治疗尿酸结石的方法。尽管UA结石的疾病负担很大,但目前的指南受到现有研究机构缺陷的限制。应开展进一步的研究,以制定诊断、治疗和预防UA尿石症的循证临床指南。
{"title":"Selection and Outcomes for Dissolution Therapy in Uric Acid Stones: A Systematic Review of Literature.","authors":"Andrea Ong,&nbsp;George Brown,&nbsp;Theodoros Tokas,&nbsp;B M Zeeshan Hameed,&nbsp;Joe Philip,&nbsp;Bhaskar K Somani","doi":"10.1007/s11934-023-01164-7","DOIUrl":"https://doi.org/10.1007/s11934-023-01164-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>The prevalence of uric acid (UA) urolithiasis contributes significantly to global disease burden, due to high rates of recurrence and diagnostic challenges. Dissolution therapy plays a valuable role in the conservative management of UA calculi, reducing the requirement for surgical intervention. This review summarises the existing evidence for the efficacy of medical dissolution of uric acid urolithiasis.</p><p><strong>Recent findings: </strong>A systematic search was conducted of worldwide literature according to PRISMA methodology and Cochrane standards for systematic review. Studies were included if they reported outcome data for the administration of medical therapy for the dissolution of UA calculi. A total of 1075 patients were included in the systematic review. Complete or partial dissolution of UA calculi was observed in 80.5% of patients (865/1075 patients), with 61.7% (647/1048 patients) achieving complete dissolution and 19.8% (207/1048 patients) achieving partial dissolution. A discontinuation rate of 10.2% (110/1075 patients) was noted, and 15.7% (169/1075 patients) required surgical intervention. Dissolution therapy is a safe and effective method of conservatively managing uric acid stones in the short term. Despite the significant disease burden of UA calculi, current guidelines are limited by deficiencies in the existing body of research. Further research should be undertaken to develop evidence-based clinical guidelines for diagnosis, treatment, and prevention of UA urolithiasis.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"355-363"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9943569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endourological Options for Small (< 2 cm) Lower Pole Stones - Does the Lower Pole Angle Matter? 小(< 2厘米)下极结石的泌尿道选择-下极角度重要吗?
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01161-w
Angus Luk, Robert Geraghty, Bhaskar Somani

Purpose of review: Small renal stones in the lower pole are often difficult to treat. The angle of the lower pole to the renal pelvis (lower pole angle) is a limiting factor to rendering the patient stone free. This review explores the definitions of the lower pole angle, the various treatment options available, and how outcomes are influenced by the angle.

Recent findings: It is clear the lower pole angle definition varies widely depending on described technique and imaging modality. However, it is clear that outcomes are worse with a steeper angle, especially for shock wave lithotripsy and retrograde intrarenal surgery (RIRS). Percutaneous nephrolithotomy has similar reported outcomes to RIRS, and there is limited evidence it may be superior for steeper angles over RIRS. Lower pole stones can be technically challenging and adequate assessment prior to choosing operative approach is key.

回顾目的:肾下极的小肾结石通常难以治疗。下极与肾盂的角度(下极角度)是使患者结石清除的限制因素。本综述探讨了下极角的定义、各种可用的治疗方案,以及下极角对预后的影响。最近的发现:很明显,根据所描述的技术和成像方式的不同,下极角的定义差异很大。然而,很明显,角度越陡,结果越差,尤其是冲击波碎石术和逆行肾内手术(RIRS)。经皮肾镜取石术与RIRS有相似的报道结果,并且有有限的证据表明经皮肾镜取石术在更陡的角度上优于RIRS。下极结石在技术上具有挑战性,在选择手术入路之前进行充分的评估是关键。
{"title":"Endourological Options for Small (< 2 cm) Lower Pole Stones - Does the Lower Pole Angle Matter?","authors":"Angus Luk,&nbsp;Robert Geraghty,&nbsp;Bhaskar Somani","doi":"10.1007/s11934-023-01161-w","DOIUrl":"https://doi.org/10.1007/s11934-023-01161-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>Small renal stones in the lower pole are often difficult to treat. The angle of the lower pole to the renal pelvis (lower pole angle) is a limiting factor to rendering the patient stone free. This review explores the definitions of the lower pole angle, the various treatment options available, and how outcomes are influenced by the angle.</p><p><strong>Recent findings: </strong>It is clear the lower pole angle definition varies widely depending on described technique and imaging modality. However, it is clear that outcomes are worse with a steeper angle, especially for shock wave lithotripsy and retrograde intrarenal surgery (RIRS). Percutaneous nephrolithotomy has similar reported outcomes to RIRS, and there is limited evidence it may be superior for steeper angles over RIRS. Lower pole stones can be technically challenging and adequate assessment prior to choosing operative approach is key.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"365-370"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10299763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Role of Bladder Functional Testing Prior to Surgeries for Benign Prostatic Obstruction. 良性前列腺梗阻手术前膀胱功能检查的作用。
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01165-6
Charles Mazeaud, Natalia Hernandez, Ricardo R Gonzalez

Purpose of review: There is no consensus on preoperative functional testing prior to surgeries for benign prostatic obstruction causing lower urinary tract symptoms (LUTS).

Recent findings: Surgical management offers definite benefits, but the results are not always satisfactory. The urodynamic study (UDS) is the gold standard for assessing bladder outlet obstruction (BOO) which is the best predictor of surgical success. Yet, it is not recommended by our urologic societies as standard testing prior to surgery. In this narrative review of the literature, we report recent findings and controversies regarding the benefits and downside of UDS, and the use of other less-invasive approaches to achieve this goal. The lack of strong evidence for or against performing UDS was surprising. Prospective UDS data may not predict surgical outcomes if there is no consensus on criteria that directs surgical intervention. However, confirming the presence of BOO and characterizing the bladder function to identify detrusor over- and underactivity may help counselling and setting patient's post-operative expectations. Urocuff, a non-invasive testing offers promising results to address this problem with a less-invasive assessment of BOO. We emphasize better pre-operative characterization of patients to confirm BOO and better define subgroups to improve surgical decision-making.

综述的目的:对于引起下尿路症状(LUTS)的良性前列腺阻塞手术前的术前功能检查尚无共识。最近的发现:手术治疗提供了明确的好处,但结果并不总是令人满意。尿动力学研究(UDS)是评估膀胱出口梗阻(BOO)的金标准,是手术成功的最佳预测指标。然而,泌尿外科协会不建议将其作为手术前的标准检查。在这篇文献综述中,我们报告了关于UDS的利弊的最新发现和争议,以及使用其他侵入性较小的方法来实现这一目标。支持或反对使用UDS的有力证据的缺乏令人惊讶。如果在指导手术干预的标准上没有共识,前瞻性UDS数据可能无法预测手术结果。然而,确认BOO的存在和描述膀胱功能以识别逼尿肌过度和活动不足可能有助于咨询和设定患者的术后期望。Urocuff是一种非侵入性测试,通过对BOO的低侵入性评估,提供了有希望的结果来解决这个问题。我们强调更好的术前特征,以确认BOO和更好地定义亚组,以改善手术决策。
{"title":"Role of Bladder Functional Testing Prior to Surgeries for Benign Prostatic Obstruction.","authors":"Charles Mazeaud,&nbsp;Natalia Hernandez,&nbsp;Ricardo R Gonzalez","doi":"10.1007/s11934-023-01165-6","DOIUrl":"https://doi.org/10.1007/s11934-023-01165-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>There is no consensus on preoperative functional testing prior to surgeries for benign prostatic obstruction causing lower urinary tract symptoms (LUTS).</p><p><strong>Recent findings: </strong>Surgical management offers definite benefits, but the results are not always satisfactory. The urodynamic study (UDS) is the gold standard for assessing bladder outlet obstruction (BOO) which is the best predictor of surgical success. Yet, it is not recommended by our urologic societies as standard testing prior to surgery. In this narrative review of the literature, we report recent findings and controversies regarding the benefits and downside of UDS, and the use of other less-invasive approaches to achieve this goal. The lack of strong evidence for or against performing UDS was surprising. Prospective UDS data may not predict surgical outcomes if there is no consensus on criteria that directs surgical intervention. However, confirming the presence of BOO and characterizing the bladder function to identify detrusor over- and underactivity may help counselling and setting patient's post-operative expectations. Urocuff, a non-invasive testing offers promising results to address this problem with a less-invasive assessment of BOO. We emphasize better pre-operative characterization of patients to confirm BOO and better define subgroups to improve surgical decision-making.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"401-407"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9944514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease-A Systematic Review of the Literature. 尿pH值监测在肾结石疾病中的作用、成本和有效性——文献系统综述
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01166-5
Isabel Sanz-Gómez, Oriol Angerri, Michael Baboudjian, Andrés Kanashiro, Sílvia Gracia, Félix Millán, Francisco Sánchez-Martín, Bhaskar Somani, Juan Antonio Galan-Llopis, Yazeed Barghouthy, Esteban Emiliani

Purpose of review: Urinary pH is an important factor related to renal stone disease, and it plays an essential role in stone prevention. Monitoring of urinary pH by patients at home provides information that can help to assess the treatment needed by each patient. We conducted a systematic review is to assess the available evidence concerning urinary pH monitoring methods along with their accuracy, cost, and usefulness by patients with urolithiasis.

Recent findings: A total of 9 articles were included (1886 urinary pH measurements). They reported information about urinary dipsticks, portable electronic pH meters and electronic strip readers, amongst other methods. Accuracy was compared with a laboratory pH meter (gold standard). Urinary dipsticks were found to be not accurate enough to guide clinical decision making and portable electronic pH meters showed promising results. Urinary dipsticks are neither precise nor accurate enough. Portable electronic pH meters seem to be more accurate, easy to use, and cost-effective. They are a reliable source for patients to use at home in order to prevent future episodes of nephrolithiasis.

综述目的:尿pH值是与肾结石疾病相关的重要因素,在肾结石的预防中起着至关重要的作用。患者在家监测尿液pH值可提供信息,帮助评估每位患者所需的治疗。我们进行了一项系统综述,以评估尿pH值监测方法的可用证据,以及它们对尿石症患者的准确性、成本和实用性。最新发现:共纳入了9篇文章(1886年尿液pH值测量)。他们报告了尿试纸、便携式电子pH计和电子试纸阅读器等方法的信息。准确度与实验室pH计(金标准)进行比较。尿试纸被发现不够准确,无法指导临床决策,便携式电子pH计显示出有希望的结果。尿试纸既不精确,也不够准确。便携式电子pH计似乎更准确,易于使用,并具有成本效益。他们是一个可靠的来源,为患者在家中使用,以防止未来的肾结石发作。
{"title":"Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease-A Systematic Review of the Literature.","authors":"Isabel Sanz-Gómez,&nbsp;Oriol Angerri,&nbsp;Michael Baboudjian,&nbsp;Andrés Kanashiro,&nbsp;Sílvia Gracia,&nbsp;Félix Millán,&nbsp;Francisco Sánchez-Martín,&nbsp;Bhaskar Somani,&nbsp;Juan Antonio Galan-Llopis,&nbsp;Yazeed Barghouthy,&nbsp;Esteban Emiliani","doi":"10.1007/s11934-023-01166-5","DOIUrl":"https://doi.org/10.1007/s11934-023-01166-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>Urinary pH is an important factor related to renal stone disease, and it plays an essential role in stone prevention. Monitoring of urinary pH by patients at home provides information that can help to assess the treatment needed by each patient. We conducted a systematic review is to assess the available evidence concerning urinary pH monitoring methods along with their accuracy, cost, and usefulness by patients with urolithiasis.</p><p><strong>Recent findings: </strong>A total of 9 articles were included (1886 urinary pH measurements). They reported information about urinary dipsticks, portable electronic pH meters and electronic strip readers, amongst other methods. Accuracy was compared with a laboratory pH meter (gold standard). Urinary dipsticks were found to be not accurate enough to guide clinical decision making and portable electronic pH meters showed promising results. Urinary dipsticks are neither precise nor accurate enough. Portable electronic pH meters seem to be more accurate, easy to use, and cost-effective. They are a reliable source for patients to use at home in order to prevent future episodes of nephrolithiasis.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"381-388"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10317951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical Aspects and Clinical Outcomes of Robotic Ureteroscopy: Is It Ready for Primetime? 机器人输尿管镜的技术方面和临床结果:它准备好了吗?
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-01 DOI: 10.1007/s11934-023-01167-4
Mriganka Mani Sinha, Vineet Gauhar, Lazaros Tzelves, Tzevat Tefik, Rifat Burak Ergul, Patrick Juliebø-Jones, Bhaskar K Somani

Purpose of review: Robotic surgery in urology has already been widely employed in robotic-assisted laparoscopic surgery for minimally invasive procedures (MIS). We wanted to analyse rapidly developing robotic ureteroscopy (RoboURS) for the treatment of renal stone disease.

Recent findings: A comprehensive literature review was performed for technical aspects and clinical outcomes of RoboURS. RoboURS has made significant breakthroughs with each model proving that this technology improves ergonomics and supports surgeon and instrument longevity while minimising musculoskeletal issues in retrograde intra-renal surgery (RIRS). Further randomised controlled trials are required to compare the efficacy of RoboURS vs manual flexible ureteroscopy (FURS). The cost-effectiveness will also need to be assessed prior to widespread acceptance into urological infrastructure and mainstream practice. RoboURS continues to evolve despite the limitations of infrastructure and cost-effectiveness. It holds the promise of a better future for surgeon longevity, reduced peri-operative morbidity and better workplace environment.

综述目的:泌尿外科机器人手术已经广泛应用于机器人辅助腹腔镜微创手术(MIS)。我们想分析快速发展的机器人输尿管镜(RoboURS)用于治疗肾结石疾病。最近的发现:对RoboURS的技术方面和临床结果进行了全面的文献综述。RoboURS在每个模型上都取得了重大突破,证明该技术改善了人体工程学,支持外科医生和器械的使用寿命,同时最大限度地减少了逆行肾内手术(RIRS)中的肌肉骨骼问题。需要进一步的随机对照试验来比较RoboURS与手动柔性输尿管镜(FURS)的疗效。成本效益也需要在广泛接受泌尿基础设施和主流实践之前进行评估。尽管受到基础设施和成本效益的限制,机器人仍在不断发展。它为外科医生的寿命、减少围手术期发病率和改善工作环境带来了美好的未来。
{"title":"Technical Aspects and Clinical Outcomes of Robotic Ureteroscopy: Is It Ready for Primetime?","authors":"Mriganka Mani Sinha,&nbsp;Vineet Gauhar,&nbsp;Lazaros Tzelves,&nbsp;Tzevat Tefik,&nbsp;Rifat Burak Ergul,&nbsp;Patrick Juliebø-Jones,&nbsp;Bhaskar K Somani","doi":"10.1007/s11934-023-01167-4","DOIUrl":"https://doi.org/10.1007/s11934-023-01167-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>Robotic surgery in urology has already been widely employed in robotic-assisted laparoscopic surgery for minimally invasive procedures (MIS). We wanted to analyse rapidly developing robotic ureteroscopy (RoboURS) for the treatment of renal stone disease.</p><p><strong>Recent findings: </strong>A comprehensive literature review was performed for technical aspects and clinical outcomes of RoboURS. RoboURS has made significant breakthroughs with each model proving that this technology improves ergonomics and supports surgeon and instrument longevity while minimising musculoskeletal issues in retrograde intra-renal surgery (RIRS). Further randomised controlled trials are required to compare the efficacy of RoboURS vs manual flexible ureteroscopy (FURS). The cost-effectiveness will also need to be assessed prior to widespread acceptance into urological infrastructure and mainstream practice. RoboURS continues to evolve despite the limitations of infrastructure and cost-effectiveness. It holds the promise of a better future for surgeon longevity, reduced peri-operative morbidity and better workplace environment.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 8","pages":"391-400"},"PeriodicalIF":2.6,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9943793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-Guided PCNL - Why Are We Still Performing Exclusively Fluoroscopic Access? 超声引导的PCNL -为什么我们仍然只进行透视访问?
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-07-01 DOI: 10.1007/s11934-023-01163-8
David T Tzou, Thomas O Tailly, Karen L Stern

Purpose of review: While urologists are traditionally taught to perform percutaneous nephrolithotomy (PCNL) utilizing exclusively fluoroscopy, ultrasound has emerged as a safe alternative. This article showcases the major reasons why ultrasound-guided access should be considered the first-line approach for performing access for PCNL.

Recent findings: There continues to be a need to further reduce radiation exposure in the management of kidney stone patients. This review showcases how performing ultrasound-guided PCNL has been associated with a shorter learning curve, increased patient safety, and the ability to perform x-ray free PCNL. Ultrasound-guided PCNL is not only an achievable skill for urologists to learn but provides multiple advantages over traditional fluoroscopic access. As every effort should be given to help reduce radiation exposure for kidney stone patients as well as performing surgeons and operating theater personnel, endourologists should strive to add this technique to their armamentarium.

回顾的目的:传统上,泌尿科医生被教导进行经皮肾镜取石术(PCNL),仅利用透视,超声已经成为一种安全的替代方法。这篇文章展示了为什么超声引导下的通路应该被认为是进行PCNL通路的一线方法的主要原因。最近的研究发现:在肾结石患者的治疗中,仍然需要进一步减少辐射暴露。这篇综述展示了超声引导下的PCNL与更短的学习曲线、更高的患者安全性以及进行无x线PCNL的能力之间的关系。超声引导下的PCNL不仅是泌尿科医生学习的一项可实现的技能,而且比传统的透视进入提供了多种优势。由于应尽一切努力帮助减少肾结石患者以及执行外科医生和手术室人员的辐射暴露,腔内科医生应努力将这项技术添加到他们的设备中。
{"title":"Ultrasound-Guided PCNL - Why Are We Still Performing Exclusively Fluoroscopic Access?","authors":"David T Tzou,&nbsp;Thomas O Tailly,&nbsp;Karen L Stern","doi":"10.1007/s11934-023-01163-8","DOIUrl":"https://doi.org/10.1007/s11934-023-01163-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>While urologists are traditionally taught to perform percutaneous nephrolithotomy (PCNL) utilizing exclusively fluoroscopy, ultrasound has emerged as a safe alternative. This article showcases the major reasons why ultrasound-guided access should be considered the first-line approach for performing access for PCNL.</p><p><strong>Recent findings: </strong>There continues to be a need to further reduce radiation exposure in the management of kidney stone patients. This review showcases how performing ultrasound-guided PCNL has been associated with a shorter learning curve, increased patient safety, and the ability to perform x-ray free PCNL. Ultrasound-guided PCNL is not only an achievable skill for urologists to learn but provides multiple advantages over traditional fluoroscopic access. As every effort should be given to help reduce radiation exposure for kidney stone patients as well as performing surgeons and operating theater personnel, endourologists should strive to add this technique to their armamentarium.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"24 7","pages":"335-343"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9683583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Urology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1